Active, not recruiting
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353
- Conditions
- Adnexal Diseases, BRCA Mutated, Endocrine Gland Neoplasms, +16 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Palo Alto Foundation Medical Group San Francisco, California, United States
- University of Colorado Aurora, Colorado, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States